Product Information
DILTIAZEM 24H ER(CD) 180 MG CP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1873 per EA under NDC 24979002702. Its NADAC has been published 379 times since Jul 3, 2019.
FDA first approved this application on Aug 30, 2018. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
24979002702
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205231FDA Approved
8/30/2018
TE Code
AB3
On Market Since
10/1/2018
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 24H ER(CD) 180 MG CP has been published 379 times since Jul 3, 2019, and over the history we have for it it has declined 31.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1873 per EA |
|---|---|
| All-time high | $0.3134 (May 12, 2021) |
| All-time low | $0.1492 (Jul 17, 2024) |
| 52-week high | $0.1877 |
| 52-week low | $0.1790 |
| Median price | $0.2031 |
| Average price | $0.2185 |
| Largest weekly change | +44.1% (Jun 19, 2024) |
| Weeks tracked | 379 |
| Tracking since | Jul 3, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diltiazem hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 24H ER(CD) 180 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(CD) 180 MG CP, manufactured by Upsher-Smith Laboratories LLC, is $0.1873 per EA (NDC 24979002702), effective Sep 30, 2026.
How has the price of DILTIAZEM 24H ER(CD) 180 MG CP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 24H ER(CD) 180 MG CP has declined 31.2%. It has been tracked across 379 weekly CMS publications since Jul 3, 2019.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(CD) 180 MG CP?
Since Jul 3, 2019, the NADAC for DILTIAZEM 24H ER(CD) 180 MG CP has ranged from a low of $0.1492 (Jul 17, 2024) to a high of $0.3134 (May 12, 2021), with a median of $0.2031 per EA.
Are there cheaper alternatives to DILTIAZEM 24H ER(CD) 180 MG CP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24H ER(CD) 180 MG CP, is $0.1794 per EA — about 4% below DILTIAZEM 24H ER(CD) 180 MG CP.
Who manufactures DILTIAZEM 24H ER(CD) 180 MG CP?
DILTIAZEM 24H ER(CD) 180 MG CP (NDC 24979002702) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.